Randomized, double-blind, multicenter, parallel group, placebo-controlled study to evaluate the efficacy and safety of phenofibrate treatment on the functions of beta cells in children and adolescents with newly diagnosed of type 1 diabetes - PRIFEN Prolonged Remission Induced by Fenofibrate

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2021
This article has no abstract
Epistemonikos ID: e6e59d6fee26cf4bb2a49fe111ab6999a55839d7
First added on: Apr 17, 2025